Informed-money record
DAWN · Day One Biopharmaceuticals, Inc.
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
0
Bearish filings
13
Named actors
5
Disclosed $ (bull / bear)
$0 / $864K
Recent disclosures
13 of 13 in the window · linked to source| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-02-17 | COO and CFO York Charles N II | sold | $70K | SEC ↗ |
| 2026-02-17 | Head of Research and Dev. VASCONCELLES MICHAEL | sold | $32K | SEC ↗ |
| 2026-02-17 | Gen Counsel & Secretary Dubow Adam | sold | $74K | SEC ↗ |
| 2026-02-17 | Chief Commercial Officer Merendino Lauren | sold | $67K | SEC ↗ |
| 2026-02-17 | CHIEF EXECUTIVE OFFICER Bender Jeremy | sold | $179K | SEC ↗ |
| 2025-11-17 | COO and CFO York Charles N II | sold | $36K | SEC ↗ |
| 2025-11-17 | Gen Counsel & Secretary Dubow Adam | sold | $38K | SEC ↗ |
| 2025-11-17 | Chief Commercial Officer Merendino Lauren | sold | $33K | SEC ↗ |
| 2025-11-17 | CHIEF EXECUTIVE OFFICER Bender Jeremy | sold | $142K | SEC ↗ |
| 2025-08-18 | Chief Commercial Officer Merendino Lauren | sold | $25K | SEC ↗ |
| 2025-08-18 | CHIEF EXECUTIVE OFFICER Bender Jeremy | sold | $109K | SEC ↗ |
| 2025-08-18 | Gen Counsel & Secretary Dubow Adam | sold | $30K | SEC ↗ |
| 2025-08-18 | COO and CFO York Charles N II | sold | $28K | SEC ↗ |
Want the read, not just the record?
Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.
Create a free account →Dispute or correct this record
Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals